Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study.
Respir Res
; 24(1): 135, 2023 May 20.
Article
in En
| MEDLINE
| ID: mdl-37210543
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pulmonary Eosinophilia
/
Asthma
/
Anti-Asthmatic Agents
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Respir Res
Year:
2023
Document type:
Article